PEP/NEWS — Peptide intel. Daily.

GLP-1 AGONISTS DO NOT CAUSE MORE MUSCLE LOSS THAN STANDARD CALORIC RESTRICTION — NEW STUDY158 DRUGS NOW IN ACTIVE ALZHEIMER'S CLINICAL TRIALS — LARGEST PIPELINE ON RECORDSLEEP UNDER 7 HRS/NIGHT RANKS 3RD STRONGEST PREDICTOR OF SHORTER LIFE IN 3,143-COUNTY US DATASETCREATINE SUPPLEMENTATION ADDS MEASURABLE BENEFIT ON TOP OF POWER TRAINING IN OLDER ADULTSINTERMITTENT HYPOXIA EQUIVALENT TO SLEEP APNEA RAISES SENESCENT CELL BURDEN IN MOUSE VASCULATUREHIF-1α AUTOPHAGIC DEGRADATION SHOWN TO EXTEND MAMMALIAN LIFESPAN IN NATURE AGINGEPIGENETIC CLOCKS SHOW WEAK SENSITIVITY TO PHYSICAL FITNESS LEVELS — NEW ANALYSISPETER ATTIA: PEPTIDES ARE LEGITIMATE BUT EVIDENCE IS CONFINED TO A NARROW SUBSET GLP-1 AGONISTS DO NOT CAUSE MORE MUSCLE LOSS THAN STANDARD CALORIC RESTRICTION — NEW STUDY158 DRUGS NOW IN ACTIVE ALZHEIMER'S CLINICAL TRIALS — LARGEST PIPELINE ON RECORDSLEEP UNDER 7 HRS/NIGHT RANKS 3RD STRONGEST PREDICTOR OF SHORTER LIFE IN 3,143-COUNTY US DATASETCREATINE SUPPLEMENTATION ADDS MEASURABLE BENEFIT ON TOP OF POWER TRAINING IN OLDER ADULTSINTERMITTENT HYPOXIA EQUIVALENT TO SLEEP APNEA RAISES SENESCENT CELL BURDEN IN MOUSE VASCULATUREHIF-1α AUTOPHAGIC DEGRADATION SHOWN TO EXTEND MAMMALIAN LIFESPAN IN NATURE AGINGEPIGENETIC CLOCKS SHOW WEAK SENSITIVITY TO PHYSICAL FITNESS LEVELS — NEW ANALYSISPETER ATTIA: PEPTIDES ARE LEGITIMATE BUT EVIDENCE IS CONFINED TO A NARROW SUBSET

Last updated May 14, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Lifespan.io
GLP-1 DRUGS DON'T CANNIBALIZE MUSCLE ANY MORE THAN PLAIN CALORIC RESTRICTION, NEW DATA SHOWS...

*GLP-1 agonists match caloric restriction for muscle loss — not worse, not better.*

Lifespan.io

Featured Briefs

▶ Video · Peptide-anchored

INFLAMMATION IS KILLING YOU, KPV IS THE ANSWER - DR TREVOR BACHMEYER

Inflammation Is Killing You (and how KPV makes statins obsolete) I explain why chronic systemic inflammation, not LDL cholesterol or blood pressure, is the real driver of heart attacks and stroke, citing CRP data from the Framingham Heart

Dr Trevor Bachmeyer
▶ Video

SLU-PP-332: WHY MORE ISN’T BETTER?

In this video, we'll be discussing SLU-PP-332, a peptide that has gained attention in the biohacking community for its potential benefits on aging and fat loss. Alex Kikel and other experts in the field have explored the effects of SLU-PP-3

The Enhanced Man

More Headlines